These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Imprinted Contact Lenses for Sustained Release of Polymyxin B and Related Antimicrobial Peptides. Malakooti N; Alexander C; Alvarez-Lorenzo C J Pharm Sci; 2015 Oct; 104(10):3386-94. PubMed ID: 26094884 [TBL] [Abstract][Full Text] [Related]
4. Bioinspired hydrogels for drug-eluting contact lenses. Alvarez-Lorenzo C; Anguiano-Igea S; Varela-García A; Vivero-Lopez M; Concheiro A Acta Biomater; 2019 Jan; 84():49-62. PubMed ID: 30448434 [TBL] [Abstract][Full Text] [Related]
5. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review. McLaughlin PJ; Sassani JW; Klocek MS; Zagon IS Brain Res Bull; 2010 Feb; 81(2-3):236-47. PubMed ID: 19683562 [TBL] [Abstract][Full Text] [Related]
6. Imprinted Contact Lenses for Ocular Administration of Antiviral Drugs. Varela-Garcia A; Gomez-Amoza JL; Concheiro A; Alvarez-Lorenzo C Polymers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899893 [TBL] [Abstract][Full Text] [Related]
8. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment. Pagar KP; Vavia PR Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187 [TBL] [Abstract][Full Text] [Related]
9. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone. Zagon IS; Sassani JW; Immonen JA; McLaughlin PJ Clin Exp Ophthalmol; 2014 Mar; 42(2):159-68. PubMed ID: 23777539 [TBL] [Abstract][Full Text] [Related]
10. Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone. Zagon IS; Sassani JW; McLaughlin PJ Cornea; 2006 Aug; 25(7):821-9. PubMed ID: 17068460 [TBL] [Abstract][Full Text] [Related]
11. Incorporation of drug particles for extended release of Cyclosporine A from poly-hydroxyethyl methacrylate hydrogels. Kapoor Y; Dixon P; Sekar P; Chauhan A Eur J Pharm Biopharm; 2017 Nov; 120():73-79. PubMed ID: 28823714 [TBL] [Abstract][Full Text] [Related]
12. Imprinted soft contact lenses as norfloxacin delivery systems. Alvarez-Lorenzo C; Yañez F; Barreiro-Iglesias R; Concheiro A J Control Release; 2006 Jul; 113(3):236-44. PubMed ID: 16777254 [TBL] [Abstract][Full Text] [Related]
13. Thermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse. Derakhshandeh K; Fashi M; Seifoleslami S Drug Des Devel Ther; 2010 Sep; 4():255-62. PubMed ID: 20957216 [TBL] [Abstract][Full Text] [Related]
14. Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing. Immonen JA; Zagon IS; McLaughlin PJ Exp Biol Med (Maywood); 2014 Oct; 239(10):1300-9. PubMed ID: 25030485 [TBL] [Abstract][Full Text] [Related]
15. Ophthalmic Econazole Hydrogels for the Treatment of Fungal Keratitis. Díaz-Tomé V; Luaces-Rodríguez A; Silva-Rodríguez J; Blanco-Dorado S; García-Quintanilla L; Llovo-Taboada J; Blanco-Méndez J; García-Otero X; Varela-Fernández R; Herranz M; Gil-Martínez M; Lamas MJ; González-Barcia M; Otero-Espinar FJ; Fernández-Ferreiro A J Pharm Sci; 2018 May; 107(5):1342-1351. PubMed ID: 29305870 [TBL] [Abstract][Full Text] [Related]
16. Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis. González-Chomón C; Silva M; Concheiro A; Alvarez-Lorenzo C Acta Biomater; 2016 Sep; 41():302-11. PubMed ID: 27221794 [TBL] [Abstract][Full Text] [Related]
17. Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation. Dixon P; Ghosh T; Mondal K; Konar A; Chauhan A; Hazra S Drug Deliv Transl Res; 2018 Oct; 8(5):1114-1126. PubMed ID: 29858820 [TBL] [Abstract][Full Text] [Related]
18. Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats. Purushothaman I; Zagon IS; Sassani JW; Mclaughlin PJ Exp Ther Med; 2021 Jul; 22(1):687. PubMed ID: 33986852 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin-Eluting Contact Lenses: Effects of Molecular Imprinting and Sterilization on Drug Loading and Release. Pereira-da-Mota AF; Vivero-Lopez M; Topete A; Serro AP; Concheiro A; Alvarez-Lorenzo C Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33922123 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo release of naltrexone from biodegradable depot systems. Liu Y; Sunderland VB; O'Neil AG Drug Dev Ind Pharm; 2006 Jan; 32(1):85-94. PubMed ID: 16455607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]